Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Suzanne Jaqueth Forrest, M.D.

Concepts (81)

Back to Profile
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
High-Throughput Nucleotide Sequencing5202436030.590 Why?
Information Dissemination1202411310.520 Why?
Molecular Targeted Therapy3202427880.400 Why?
Neoplasms62024218990.380 Why?
Glioma1202234000.290 Why?
Medical Oncology1201822900.260 Why?
Pediatrics1201835820.210 Why?
Brain Neoplasms1202289170.190 Why?
Mutation32024297640.180 Why?
Child122024794180.160 Why?
Muscular Atrophy, Spinal220122590.160 Why?
Proto-Oncogene Proteins c-ret120202240.150 Why?
Fibrosarcoma120203070.150 Why?
Resource Allocation120203450.150 Why?
Microtubule-Associated Proteins1202210750.140 Why?
Osteosarcoma120238980.140 Why?
Oncogenes1202212180.140 Why?
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma120203820.140 Why?
Interleukin-21202318720.140 Why?
Infant62024358280.130 Why?
Child, Preschool72024418480.130 Why?
Specimen Handling120207060.130 Why?
Neoplasm, Residual1202010010.130 Why?
Central Nervous System Neoplasms120239070.120 Why?
Antineoplastic Agents12018135780.120 Why?
Base Sequence12022124390.100 Why?
Soft Tissue Neoplasms1202011530.090 Why?
Genomics2202457420.090 Why?
Graft vs Host Disease1202330050.090 Why?
Bone Neoplasms1202325320.090 Why?
Adolescent62024872970.080 Why?
Clinical Trials as Topic1202480140.080 Why?
Infant, Newborn22024260340.070 Why?
Ovarian Neoplasms1202348760.070 Why?
Protein Kinase Inhibitors1202256130.070 Why?
Prognosis32023294630.060 Why?
Biomedical Research1202033900.060 Why?
Gene Expression Regulation, Neoplastic1202084380.060 Why?
Humans1420247561110.060 Why?
DNA Copy Number Variations1201220040.050 Why?
Survival of Motor Neuron 2 Protein22012480.050 Why?
Follow-Up Studies22020391870.050 Why?
Loss of Heterozygosity120236600.050 Why?
Oncogene Fusion12020810.040 Why?
Antineoplastic Combined Chemotherapy Protocols12020116070.040 Why?
Tissue Banks120201830.040 Why?
BRCA2 Protein120237920.040 Why?
Female620243882290.040 Why?
Gene Amplification1202310810.040 Why?
Male520243568520.040 Why?
BRCA1 Protein1202311340.030 Why?
Clinical Trials, Phase III as Topic120208560.030 Why?
Young Adult42023581430.030 Why?
Germ-Line Mutation1202318260.030 Why?
Remission Induction1202023900.030 Why?
Phenotype12012164420.030 Why?
Severity of Illness Index12012157730.030 Why?
Analysis of Variance2201262440.030 Why?
Motor Activity2201226880.020 Why?
Oncogene Proteins, Fusion1202015850.020 Why?
Gas Chromatography-Mass Spectrometry120123520.020 Why?
Prospective Studies32023540400.020 Why?
Fatty Acids, Nonesterified120123930.020 Why?
Biopsy1202067600.020 Why?
Chromatography, Liquid120129800.020 Why?
DNA Primers1201228100.020 Why?
Gene Dosage1201212190.020 Why?
Immunotherapy1202346100.020 Why?
Survival Rate12020127900.020 Why?
Amino Acids1201217150.020 Why?
Tandem Mass Spectrometry1201211790.020 Why?
Case-Control Studies22012219170.010 Why?
Randomized Controlled Trials as Topic12020102560.010 Why?
Retrospective Studies22023797460.010 Why?
Metabolomics1201216130.010 Why?
Cross-Sectional Studies22012257150.010 Why?
Pilot Projects1201284980.010 Why?
Proteomics1201237610.010 Why?
Adult220222183020.010 Why?
Gene Expression Profiling1201293410.010 Why?
Age Factors12012183720.010 Why?
Forrest's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (81)
Explore
_
Co-Authors (63)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.